News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Covidien plc (COV)'s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians



5/21/2013 11:36:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its superDimension Electromagnetic Navigation Bronchoscopy (ENB™) system, the first technology of its kind, is included in the new American College of Chest Physicians (ACCP) guidelines to aid in diagnosing and managing lung cancer. The evidence-based clinical practice guidelines were released by the ACCP earlier this month.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES